Bert A. D. Windhorst

Amsterdam University Medical Centers

Papers

1

Total Citations

27

H-Index

1

About

Bert A. D. Windhorst is a leading researcher in the field of oncological imaging, with a specific focus on improving the detection and characterization of prostate cancer. His primary research areas center on the development and clinical validation of advanced hybrid imaging techniques, particularly the integration of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) with multiparametric magnetic resonance imaging (mpMRI). Windhorst’s major contribution lies in demonstrating the superior diagnostic accuracy of PSMA-PET/MRI over conventional mpMRI alone for detecting clinically significant prostate cancer. His landmark work, the ProStaPET study, prospectively compared these modalities against the gold standard of radical prostatectomy histopathology, providing critical evidence that PSMA-PET/MRI significantly enhances the localization of aggressive tumors. This study, which has garnered 27 citations, is a cornerstone in the shift toward more precise, non-invasive prostate cancer diagnosis. By quantifying the added value of molecular imaging, Windhorst’s research directly impacts clinical decision-making, potentially reducing unnecessary biopsies and guiding more effective, personalized treatment strategies for patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
27
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study
27 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Amsterdam University Medical Centers

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago